Wound management system and methods of using

Patent metadata

Field	Value
Publication number	US-10201631-B2
Application number	US-201715661972-A
Country	US
Kind code	B2
Filing date	Jul 27, 2017
Priority date	Mar 21, 2014
Publication date	Feb 12, 2019
Grant date	Feb 12, 2019

Abstract

A wound management system can comprise a surgically acceptable adhesive disposed over a wound and a surgically acceptable film repositionably disposed over the surgically acceptable adhesive, and methods of managing a wound involving the same.

First claim

We claim:

1. A wound management system, comprising
a surgically acceptable skin adhesive disposed over and in direct contact with a wound; and
a surgically acceptable film repositionably disposed over the surgically acceptable skin adhesive, wherein both the surgically acceptable skin adhesive and the surgically acceptable film cover the wound.

2. The wound management system of claim 1 , wherein the surgically acceptable skin adhesive is a cyanoacrylate adhesive.

3. The wound management system of claim 2 , wherein the surgically acceptable skin adhesive comprises at least one of butylcyanoacrylate and octylcyanoacrylate.

4. The wound management system of claim 3 , wherein the surgically acceptable adhesive comprises octylcyanoacrylate.

5. The wound management system of claim 1 , wherein the surgically acceptable film is in contact with the surgically acceptable skin adhesive.

6. The wound management system of claim 5 , wherein the surgically acceptable film comprises a first side and a second side, the first side having a pressure sensitive adhesive disposed thereon.

7. The wound management system of claim 1 , wherein the surgically acceptable film comprises a silicone sheet.

8. The wound management system of claim 1 , wherein the surgically acceptable film comprises a silicone adhesive.

9. The wound management system of claim 1 , wherein the surgically acceptable film is formed by disposing a curable gel or curable liquid over the surgically acceptable skin adhesive and curing the curable gel or curable liquid into a film.

10. The wound management system of claim 1 , wherein the surgically acceptable film is permeable to at least one of air, moisture, blood, and wound exudate.

11. The wound management system of claim 1 , wherein the surgically acceptable film is semi-permeable to at least one of air, moisture, blood, and wound exudate.

12. The wound management system of claim 1 , wherein the surgically acceptable film is impermeable to at least one of air, moisture, blood, and wound exudate.

13. The wound management system of claim 1 , wherein the surgically acceptable film is transparent or translucent.

14. The wound management system of claim 1 , wherein the surgically acceptable film is opaque.

15. The wound management system of claim 1 , wherein the surgically acceptable film is adapted to change from transparent or translucent to opaque.

16. The wound management system of claim 1 , wherein the surgically acceptable film is in the form of a surgically acceptable tape, dressing or bandage.

17. The wound management system of claim 1 , wherein the surgically acceptable adhesive is an atraumatic adhesive.

18. The wound management system of claim 1 , wherein the surgically acceptable film comprises one or more of silicone, paper, cellulose, microporous material, polyamide, and polyacrylate, polyester, copolyester, and fabric.

19. The wound management system of claim 18 , wherein the surgically acceptable film comprises silicone.

20. The wound management system of claim 19 , wherein the surgically acceptable film has a first surface comprising silicone and a second surface comprising one or more of paper, cellulose, microporous material, polyamide, and polyacrylate, polyester, copolyester, and fabric.

21. The wound management system of claim 1 , wherein the surgically acceptable film is perforated.

22. The wound management system of claim 1 , wherein the surgically acceptable film is not perforated.

23. The wound management system of claim 1 , further comprising an absorbent dressing disposed over the surgically acceptable film.

24. The wound management system of claim 1 , further comprising at least one topically administrable active agent.

25. The wound management system of claim 24 , wherein the topically administrable active agent comprises one or more of antimicrobials, moisturizers, vitamins, skin nutrients, beneficial oils, and scar reducing agents.

26. The wound management system of claim 1 , wherein the surgically acceptable film comprises one or more markings delineating one or more pre-determined shapes on the film.

27. The wound management system of claim 3 , wherein the surgically acceptable skin adhesive has an amount from about 0.1 mL to about 10 mL.

Assignees

• Medline Ind Inc

Inventors

• Duncan Angie
• Donovan Bridget
• Chakravarthy Debashish
• Miller Maria

Classifications

• A61L15/58

  Adhesives · CPC title

• A61L15/44

  Medicaments · CPC title

• A61L15/42 Primary

  Use of materials characterised by their function or physical properties (liquid bandages A61L26/00) · CPC title

• A61L2300/22

  Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes · CPC title

• A61L2300/428

  Vitamins, e.g. tocopherol, riboflavin · CPC title